FSD Pharma Inc.
HUGE · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $2,367 | $1,985 | $2,317 | $1,221 |
| - Cash | $3 | $17 | $35 | $18 |
| + Debt | $0 | $1 | $1 | $1 |
| Enterprise Value | $2,365 | $1,969 | $2,282 | $1,204 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$3 | -$4 | -$4 | -$4 |
| % Margin | – | – | – | – |
| EBITDA | -$16 | -$22 | -$30 | -$24 |
| % Margin | – | – | – | – |
| Net Income | -$19 | -$23 | -$35 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.47 | -0.6 | -1.01 | -2.72 |
| % Growth | 21.7% | 40.6% | 62.9% | – |
| Operating Cash Flow | -$11 | -$28 | -$21 | -$19 |
| Capital Expenditures | -$0 | -$0 | -$1 | $0 |
| Free Cash Flow | -$11 | -$29 | -$21 | -$19 |